Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sardelić

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Clinical Pharmacology and Therapeutics|August 1, 1995
The role of oral dihydroergotamine in the management of vascular disordersZ Rumboldt, J Bagatin, S Sardelić
European Journal of Clinical Pharmacology|January 1, 1995
Secondary prevention of myocardial infarction: impact of clinical trials on clinical practiceZ Rumboldt, I Bozić, S Sardelić
Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti|October 28, 2017
[MULTIRESISTANT BACTERIA]B Bedenić, S Sardelić, M Ladavac
Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti|January 1, 1993
How much do we know about hyperuricemia and gout? The expectations and the resultsZ Rumboldt, J Bagatin, M Simunić, et al.
European Heart Journal|November 1, 1995
Acute myocardial infarction in the young--the role of smokingZ Rumboldt, M Rumboldt, S Pesenti, et al.
Lancet (London, England)|February 5, 1998
Visceral leishmaniasis in southern CroatiaV Punda-Polić, S Sardelić, N Bradarić
International Journal of Clinical Pharmacology Research|January 1, 1995
Vascular effects of chlorthalidone in mild hypertensivesJ Bagatin, I Pavlicević, S Sardelić, et al.
Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti|May 26, 1998
QT interval as a marker of venous reactivity in dialysis patientsD Ljutić, S Sardelić, J Bagatin, et al.
Lijecnicki Vjesnik|May 1, 1993
[How much do we understand about pharmacotherapy of cardiac arrhythmias?]S Sardelić, Z Rumboldt, M Simunić, et al.
Lijecnicki Vjesnik|January 1, 1995
[The vasodilating effect of chlorthalidone in mild hypertension evaluated by impedance venous plethysmography]J Bagatin, S Sardelić, Z Rumboldt, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Clinical Pharmacology and Therapeutics|August 1, 1995
The role of oral dihydroergotamine in the management of vascular disordersZ Rumboldt, J Bagatin, S Sardelić
European Journal of Clinical Pharmacology|January 1, 1995
Secondary prevention of myocardial infarction: impact of clinical trials on clinical practiceZ Rumboldt, I Bozić, S Sardelić
Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti|October 28, 2017
[MULTIRESISTANT BACTERIA]B Bedenić, S Sardelić, M Ladavac
Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti|January 1, 1993
How much do we know about hyperuricemia and gout? The expectations and the resultsZ Rumboldt, J Bagatin, M Simunić, et al.
European Heart Journal|November 1, 1995
Acute myocardial infarction in the young--the role of smokingZ Rumboldt, M Rumboldt, S Pesenti, et al.
Lancet (London, England)|February 5, 1998
Visceral leishmaniasis in southern CroatiaV Punda-Polić, S Sardelić, N Bradarić
International Journal of Clinical Pharmacology Research|January 1, 1995
Vascular effects of chlorthalidone in mild hypertensivesJ Bagatin, I Pavlicević, S Sardelić, et al.
Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti|May 26, 1998
QT interval as a marker of venous reactivity in dialysis patientsD Ljutić, S Sardelić, J Bagatin, et al.
Lijecnicki Vjesnik|May 1, 1993
[How much do we understand about pharmacotherapy of cardiac arrhythmias?]S Sardelić, Z Rumboldt, M Simunić, et al.
Lijecnicki Vjesnik|January 1, 1995
[The vasodilating effect of chlorthalidone in mild hypertension evaluated by impedance venous plethysmography]J Bagatin, S Sardelić, Z Rumboldt, et al.
Pageof 2